Stock & Company Details
Immix Biopharma Inc $IMMX
Price:
N/A
N/A
72M
$674M
52 Week High:
N/A
10 Day Average Volume:
N/A
-8.80
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
IMMX technical indicators
Latest Immix Biopharma Inc (IMMX) indicator readings as of 2026-10-29.
IMMX's 14-day RSI is 32.7, in neutral territory. At $7.98 it is trading 15.7% below its 200-day moving average of $9.47, and below its 50-day average of $11.13. Price sits in the middle of its Bollinger Bands ($7.44 to $10.07). ADX reads 41.1, indicating a trending market.
Overview
Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. It has two business units ImmixBio and Nexcella.
Finance Bot
Ask your questions
Start by typing a question below.
